Skip to main content
TipRanks
Go Ultimate75% OFF

Aino Health AB (50V) AI Stock Analysis

0 Followers
DE:50V

Aino Health AB

(Frankfurt:50V)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Digital health business modelAino operates in a defined digital health and corporate health management niche, addressing employer absenteeism and work-ability processes. Its software-and-services model can support repeat organizational use when employers rely on reporting and structured workflows to manage workforce health.
Negative Factors
Persistent operating lossesAino combines modest revenue contraction with deeply negative operating and net margins, showing that its current revenue base does not cover the cost of running the business. Persistent losses weaken internal funding capacity and make a durable path to profitability unproven.

Aino Health AB (50V) vs. iShares MSCI Germany ETF (EWG)

-25%0%25%50%75%100%125%150%DE:50V-7.69%EWG+9.15%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 3.65M
Dividend Yield
―
Average Volume (3M)
160.67K
Price to Earnings (P/E)
-4.1
Beta (1Y)
-64.39
Revenue Growth
-8.73%
EPS Growth
-62.96%
Country
Germany
Employees
18
Sector
Healthcare
Sector Strength
51
Industry
Medical - Healthcare Information Services

Aino Health AB Business Overview & Revenue Model

Company Description

Aino Health AB (publ), a Swedish company based in Stockholm, specializes in delivering comprehensive corporate health management solutions to both private and public organizations throughout Finland. Their flagship offering is HealthManager, a Softwa...

Aino Health AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:50V against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:SUSSE:SUS73OutperformSEK 3.18B30.38――8.40%0.74%
SE:PTRKSE:PTRK59NeutralSEK 183.75M-2.10――-10.30%-11.59%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SE:KONTSE:KONT47NeutralSEK 46.00M-42.41-1.94%―0.97%41.35%
SE:QLINEASE:QLINEA40UnderperformSEK 263.39M-1.53-48.10%―33.26%90.73%

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%DE:50VSE:QLINEASE:KONTSE:SUSSE:PTRKDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:50V and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:50VAino Health AB0.01-0.00-7.69%
SE:QLINEAQ-linea AB13.25-12.57-48.67%
SE:KONTKontigo Care AB1.30-0.60-31.68%
SE:SUSSurgical Science Sweden AB55.60-16.95-23.36%
SE:PTRKPhysitrack Limited11.25-3.85-25.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.